Nucleai
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Domain
nucleai.ai
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
51-100
Last Funding
$14.0M
Founded
2016
Tech Stack (3 technologies)
Frequently Asked Questions
What technologies does Nucleai use?+
Nucleai uses 3 technologies including Google Font API, HSTS, Sucuri.
What industry is Nucleai in?+
Nucleai operates in the Artificial Intelligence (AI) industry.
Where is Nucleai based?+
Nucleai is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026